apMNKQ2 also inhibits eIF4E phosphorylation in breast cancer cells [37]; however, in NSCLC cells, apMNKQ2 did not affect eIF4E phosphorylation, which is in accordance with other MNK inhibitors such as apMNK2F and apMNK3R aptamers [36] or ferrocene analogs [62]. The gene discussed is ATP7A; the disease is breast carcinoma.